Summit Therapeutics PLC (SMMT)
ETFs that hold Summit Therapeutics PLC (SMMT)
Summit Therapeutics PLC is held by 11 ETFs tracked in our database. The largest position is held by XBI (0.56%), a sector fund. The remaining funds hold it at 0.16% or less. The largest holders are mostly sector and small-cap funds.
ETFs holding Summit Therapeutics PLC (SMMT) in our database, ranked by portfolio weight.
Which ETFs hold Summit Therapeutics PLC (SMMT)?
The ETFs with the largest positions in Summit Therapeutics PLC (SMMT) are: SPDR S&P Biotech ETF (XBI, 0.56%); iShares Biotechnology ETF (IBB, 0.16%); Vanguard Small-Cap Value ETF (VBR, 0.06%); Vanguard Small-Cap ETF (VB, 0.02%); iShares Russell Mid-Cap ETF (IWR, 0.02%). The full list, ranked by weight, is in the table.
How many ETFs hold Summit Therapeutics PLC (SMMT)?
Summit Therapeutics PLC (SMMT) is held by 11 ETFs tracked in our database. The largest position is in XBI, where it makes up 0.56% of the fund's assets.
What does the ETF weight mean?
The weight is the share of a fund's assets invested in the stock. It shows how much passive index-fund ownership the stock has and where it carries the most influence. XBI holds Summit Therapeutics PLC (SMMT) at 0.56%, and the simple average weight across the 11 funds is 0.08%.